Metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming a pressing health issue in the Middle East and North Africa (MENA). However, there’s still a lot to figure out in terms of how well prepared health systems are to address it. A recent study took a close look at the current care models, resources, and perspectives of healthcare providers in 17 MENA countries.
Researchers surveyed 130 specialists involved in MASLD care from various sectors—academic, public, and private. They focused on national policies, diagnostic methods, treatment strategies, multidisciplinary team (MDT) collaboration, and community engagement. The study aimed to assess how these factors influence the management of MASLD.
The findings were sobering. Only 35% of experts indicated that their countries have national clinical guidelines for MASLD, while a significant 73% noted the absence of a coordinated national strategy. Just 39% reported having structured referral pathways for patients, and only about a third felt that the current care models were sufficient. Though 60% supported MDT approaches, the reality was that these methods were not consistently applied. Over a quarter of providers lacked access to important diagnostic tools like transient elastography, and public awareness efforts were dismal—many reported having no resources to educate patients. Almost half of the clinicians pointed out that patient adherence to treatment is often poor, largely due to lack of awareness, financial struggles, and inadequate follow-up care.
Overall, these results indicate serious shortcomings in MASLD care in the MENA region. There’s a clear need for better national strategies, effective guidelines, and improved teamwork among healthcare providers. Engaging and educating the public is just as crucial. According to a 2022 study by the World Health Organization, over 60% of liver disease patients globally are unaware that they even have a liver problem. This highlights the urgent need for proactive public health campaigns.
Experts believe that improving MASLD care requires more than just medical solutions. It calls for a fundamental shift in how health systems operate. Feedback from frontline clinicians shows they are ready for change. They emphasize the importance of integrated strategies, patient-centered care, and comprehensive public awareness initiatives. Moving from a reactive stance to a more organized, proactive approach can significantly enhance diagnosis, long-term management, and equitable access to care for MASLD patients across the region. This is essential for not only addressing MASLD but also for strengthening the overall health system.
For more detailed insights, you can view the original study: Mapping Metabolic Dysfunction-associated Steatotic Liver Disease across MENA.
Source link
Liver, Liver Disease, Diagnostic, Education, Healthcare, Hepatology, Research
